Metraipolis › archive › dc_127c6ca3abba
Frontiers in Antibody-Drug Conjugates: Mechanisms, Design Innovations, and Clinical Applications in Targeted Cancer Therapy — Europe PMC PMID:41754865
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41754865
- DOI
- 10.3390/ph19020324
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T19:25:57.655Z
- SHA-256 of the archived text
2aec34728389aba299c92b91563b65ae7338fb758325f864ea26a3cbd62b738f- Stable URL of this page
https://metraipolis.com/documento/dc_127c6ca3abba
How to cite
Frontiers in Antibody-Drug Conjugates: Mechanisms, Design Innovations, and Clinical Applications in Targeted Cancer Therapy — Europe PMC PMID:41754865 — Europe PMC (en), https://europepmc.org/article/MED/41754865 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_127c6ca3abba (Metraipolis archive dc_127c6ca3abba, sha256 2aec34728389aba299c92b91563b65ae7338fb758325f864ea26a3cbd62b738f)
BibTeX
@misc{dc127c6ca3abba,
title = {Frontiers in Antibody-Drug Conjugates: Mechanisms, Design Innovations, and Clinical Applications in Targeted Cancer Therapy — Europe PMC PMID:41754865},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41754865},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_127c6ca3abba; sha256 2aec34728389aba299c92b91563b65ae7338fb758325f864ea26a3cbd62b738f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41754865. Agents can read the archived copy with the MCP tool read_document.